Anthony J. Aldave, MD, received his medical degree from the University of Texas Medical Branch in Galveston. He performed his residency training in ophthalmology at the Wills Eye Hospital, Thomas Jefferson University, in Philadelphia, Pennsylvania. Dr. Aldave then completed a two-year Cornea, Uveitis and Refractive Surgery Fellowship at The University of California, San Francisco/ Francis I. Proctor Foundation. He joined the Stein Eye Institute in July 2002 as a full-time member of the Cornea and Refractive Surgery Services. Dr. Aldave is currently a Professor of Ophthalmology, holds the Walton Li Chair in Cornea and Uveitis, is Chief of the Cornea and Uveitis Division and Director of the Cornea and Refractive Surgery Fellowship Program.
Dr. Aldave has received numerous honors during his career, including the Alpha Omega Alpha Scholarship Award for graduating first in his medical school class, the Heed Ophthalmic Foundation Fellowship, the American Ophthalmological Society-Knapp Testimonial Fund Fellowship, the first Claes Dohlman Society Award, and the Achievement, Secretariat and Senior Achievement Awards from the American Academy of Ophthalmology.
In addition to his busy clinical practice, Dr. Aldave directs the Corneal Genetics Laboratory at the Stein Eye Institute. Dr. Aldave’s NIH-funded laboratory research focuses on the molecular genetics of the corneal dystrophies, a group of inherited disorders that affect corneal clarity and constitute one of the primary indications for corneal transplantation. Recognized as a leader in his chosen field of scientific investigation, Dr. Aldave has authored over 125 peer-reviewed scientific publications, has been invited to give more than 350 presentations at local, national and international meetings and serves as a scientific reviewer for 18 ophthalmology and genetics journals.
On Dr. Aldave’s first trip to India in 2002, he was overwhelmed by the significant social and economic burden of visual impairment secondary to corneal opacification in India, where it is estimated that approximately 7 million individuals suffer from corneal blindness in at least one eye. The following year, Dr. Aldave began performing artificial corneal transplant surgery at the Jules Stein Eye Institute, where he has subsequently performed over 100 procedures. Given the ability of the artificial cornea (keratoprosthesis) to restore vision to patients without the need for high-quality donor tissue, and without the need to be concerned about transplant rejection, Dr. Aldave becomes interested in the feasibility of introducing the artificial cornea to the developing world.
In 2008, Dr. Aldave founded Visionaries International with the purpose of training corneal surgeons in India and throughout the world to perform keratoprosthesis surgery. For more information regarding Visionaries International please visit www.visionaries-international.org.